Pert CB - Search Results

1

Profound anti-HIV-1 activity of DAPTA in monocytes/macrophages and inhibition of CCR5-mediated apoptosis in neuronal cells.

Pollicita M, Ruff MR, Pert CB, Polianova MT, Schols D, Ranazzi A, Perno CF, Aquaro S. Pollicita M, et al. Among authors: pert cb. Antivir Chem Chemother. 2007;18(5):285-95. doi: 10.1177/095632020701800504. Antivir Chem Chemother. 2007. PMID: 18046961 Free article.

2

Chemokine receptor-5 (CCR5) is a receptor for the HIV entry inhibitor peptide T (DAPTA).

Polianova MT, Ruscetti FW, Pert CB, Ruff MR. Polianova MT, et al. Among authors: pert cb. Antiviral Res. 2005 Aug;67(2):83-92. doi: 10.1016/j.antiviral.2005.03.007. Antiviral Res. 2005. PMID: 16002156

3

Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA).

Polianova MT, Ruscetti FW, Pert CB, Tractenberg RE, Leoung G, Strang S, Ruff MR. Polianova MT, et al. Among authors: pert cb. Peptides. 2003 Jul;24(7):1093-8. doi: 10.1016/s0196-9781(03)00176-1. Peptides. 2003. PMID: 14499289 Clinical Trial.

4

Update on D-ala-peptide T-amide (DAPTA): a viral entry inhibitor that blocks CCR5 chemokine receptors.

Ruff MR, Polianova M, Yang QE, Leoung GS, Ruscetti FW, Pert CB. Ruff MR, et al. Among authors: pert cb. Curr HIV Res. 2003 Jan;1(1):51-67. doi: 10.2174/1570162033352066. Curr HIV Res. 2003. PMID: 15043212 Review.

5

Peptide T inhibits HIV-1 infection mediated by the chemokine receptor-5 (CCR5).

Ruff MR, Melendez-Guerrero LM, Yang QE, Ho WZ, Mikovits JW, Pert CB, Ruscetti FA. Ruff MR, et al. Among authors: pert cb. Antiviral Res. 2001 Oct;52(1):63-75. doi: 10.1016/s0166-3542(01)00163-2. Antiviral Res. 2001. PMID: 11530189

6

Attenuation of rodent neuropathic pain by an orally active peptide, RAP-103, which potently blocks CCR2- and CCR5-mediated monocyte chemotaxis and inflammation.

Padi SSV, Shi XQ, Zhao YQ, Ruff MR, Baichoo N, Pert CB, Zhang J. Padi SSV, et al. Among authors: pert cb. Pain. 2012 Jan;153(1):95-106. doi: 10.1016/j.pain.2011.09.022. Epub 2011 Oct 26. Pain. 2012. PMID: 22033364

7

VIP1-12 is a ligand for the CD4/human immunodeficiency virus receptor.

Sacerdote P, Ruff MR, Pert CB. Sacerdote P, et al. Among authors: pert cb. Ann N Y Acad Sci. 1988;527:574-8. doi: 10.1111/j.1749-6632.1988.tb27010.x. Ann N Y Acad Sci. 1988. PMID: 2839089 No abstract available.

8

Cholecystokinin and the immune system: receptor-mediated chemotaxis of human and rat monocytes.

Sacerdote P, Ruff MR, Pert CB. Sacerdote P, et al. Among authors: pert cb. Peptides. 1988;9 Suppl 1:29-34. doi: 10.1016/0196-9781(88)90219-7. Peptides. 1988. PMID: 2856648

9

Peptide T[4-8]: a pentapeptide sequence in the AIDS virus envelope which blocks infectivity is essentially conserved across nine isolates.

Pert CB, Ruff MR. Pert CB, et al. Clin Neuropharmacol. 1986;9 Suppl 4:482-4. Clin Neuropharmacol. 1986. PMID: 3646092 No abstract available.

10

Peptide T blocks GP120/CCR5 chemokine receptor-mediated chemotaxis.

Redwine LS, Pert CB, Rone JD, Nixon R, Vance M, Sandler B, Lumpkin MD, Dieter DJ, Ruff MR. Redwine LS, et al. Among authors: pert cb. Clin Immunol. 1999 Nov;93(2):124-31. doi: 10.1006/clim.1999.4771. Clin Immunol. 1999. PMID: 10527688 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

197 results

Search Page